This story has been updated from a previous version to incorporate information about Sysmex's acquisition of Partec.

NEW YORK (GenomeWeb News) — Japanese in vitro diagnostics firm Sysmex said yesterday that it has acquired a pair of German companies in a bid to bolster its personalized medicine and companion diagnostics development business.

Specifically, Sysmex acquired Hamburg-based Inostics and its US subsidiary Inostics Inc., based in Baltimore, Md. Sysmex has also acquired Görlitz-based flow cytometry firm Partec.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.